IFN-ALPHA AND HIV GP120 IN NEUROAIDS STUDIES
IFN-ALPHA AND HIV GP120 IN NEUROAIDS STUDIES
批准号:
6539175
负责人:
IAIN Leslie CAMPBELL
金额:
$46.3万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-07-01 至 2005-06-30
中文摘要
描述(改编自申请人的摘要):感染该病毒的个人
人类免疫缺陷病毒 (HIV-1) 经常表现出严重、进行性的症状
行为认知和运动缺陷(称为 NeuroAIDS)。与
大脑的病理变化。有证据表明发病机制
NeuroAIDS 涉及由 (1) 介导的神经毒性途径的组合
宿主反应的产物,以 IFNα 为代表,从激活的细胞中释放出来
巨噬细胞/小胶质细胞和星形胶质细胞和 (2) HIV-1 产品,例如信封
蛋白质 gp120。如初步结果所示,转基因 (tg) 小鼠
星形胶质细胞表达 IFNα 或 gp120 概括了许多
NeuroAIDS 的结构和功能特征,并将用于
拟议的研究。通过这些因素来确定性质和机制
以及CXC趋化因子IP-10影响程度和进展
中枢神经系统的结构和功能损伤。的分子基础
IFNα 和 gp120 在 CNS 中的作用尚不清楚,有待进一步研究
检查与 tg 神经病理学变化的发展有关
老鼠。在旨在检查关键信号转导途径的研究中,
申请人将确定信号传感器的性质和作用,以及
转录激活剂 (STAT) 和细胞因子信号转导抑制剂
((SOCS)在临床、细胞和分子改变的发展中
在 IFNα 和 gp120 tg 小鼠的中枢神经系统中。多方面的方法将
用于这些研究,这些研究将(I)定义时间和空间
STAT 和 SOCS 基因在 CNS 中的表达,并且 (ii) 评估
IFNα 或 gp120 中 STAT 信号丢失的结构后果
STAT 基因表达缺陷的 tg 小鼠。的潜力
当 IFNα 和 gp120 作用时产生协同/累加神经毒性
中枢神经系统中的共表达将在双基因小鼠共表达中进行评估
IFNα 和 gp120 以及 CNS 结构的改变将与
单独 tg 和野生型小鼠。 CXC 趋化因子 IP-10 显着表达
在 IFNα 和 gp120 tg 小鼠以及 NeuroAIDS 患者的中枢神经系统中。至
为了确定 IP-10 对 CNS 的影响,研究人员将使用 tg 小鼠
最近开发的星形胶质细胞表达 IP-10 或
IP-10 受体 CXCR3 表达缺陷的基因敲除小鼠。
这些 tg 和 KO 小鼠将与 IFNα 或 gp120 小鼠杂交,
中枢神经系统结构和功能的改变将与单独的 tg 和
野生型小鼠。确定结构损坏的程度
y 宿主和病毒因素反映在神经元功能的变化中,
将在上述小鼠中分析海马切片生理学。的
该提案的结果将增进我们对基本原理的理解
关键宿主和病毒因素在发病机制中的作用机制
NeuroAIDS 可能有助于确定重要的治疗靶点
干预措施。
英文摘要
Description (Adapted from Applicant's abstract): Individuals infected with the
human immunodeficiency virus (HIV-1) frequently exhibit serious, progressive
behavioral cognitive and motor deficits (termed NeuroAIDS). In association with
pathological changes in the brain. Evidence suggests the pathogenesis of
NeuroAIDS involves a combination of neurotoxic pathways mediated by (1)
products of the host response exemplified by IFNalpha, released from activated
macrophages/microglia and astroglia and (2) HIV-1 products e.g. the envelope
protein gp120. As demonstrated in Preliminary Results, transgenic (tg) mice
with astrocyte expression of IFNalpha or gp120 recapitulate many of the
structural and functional features of NeuroAIDS and will be used in the
proposed studies. To determine the nature and mechanisms by with these factors
as well as the CXC chemokine IP-10 influence the degree and progression of
structural and functional injury in the CNS. The molecular basis for the
actions of IFNalpha and gp120 in the CNS are poorly understood and will be
examined in relation to the development of neuropathological changes in the tg
mice. In studies designed to examine critical signal transduciton pathways, the
applicant will determine the nature and role of the signal transducers and
activators of transcription (STAT) and suppressors of cytokine signaling
((SOCS) in the development of the clinical, cellular and molecular alterations
in the CNS of the IFNalpha and the gp120 tg mice. A multifaceted approach will
be employed for these studies which will (I) define the temporal and spatial
expression of the STAT and SOCS genes in the CNS and (ii) evaluate the
structural consequences of the loss of STAT signaling in the IFNalpha or gp120
tg mice deficient in STAT gene expression. The potential for
synergistic/additive neurotoxicity produced when IFNalpha and gp120 are
co-expressed in the CNS will be assessed in bi-genic mice co-expressing
IFNalpha and gp120 and the structural CNS alterations will be compared with
singly tg and wild type mice. The CXC chemokine IP-10 is prominently expressed
in the CNS of the IFNalpha and gp120 tg mice and in patients with NeuroAIDS. To
ascertain the CNS effects of IP-10, the investigators will utilize tg mice they
recently developed exhibiting astrocyte expression of the IP-10 or
gene-knockout mice deficient for the expression of the IP-10- receptor CXCR3.
These tg and KO mice will be cross bred with IFNalpha or gp120 mice and the
structural and functional CNS alterations will be compared with singly tg and
wild type mice. To determine the extent to which the structural damage produced
y the host and viral factors is reflected in a change in neuronal function,
hippocampal slice physiology will be analyzed in the mice described above. The
results from this proposal will advance our understanding of the fundamental
mechanisms of action of key host and viral factors in the pathogenesis of
NeuroAIDS and may help to identify important targets for therapeutic
interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
-
批准号:6911638
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2004
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
-
批准号:7234038
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2004
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
-
批准号:7432448
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2004
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
-
批准号:7056082
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2004
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
CNS Pathobiology of IFN-inducible non-ELR CXC Chemokines
-
批准号:6704589
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2004
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
Project 3
-
批准号:6594213
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2002
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
Project 3
-
批准号:6663386
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2002
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
Project 3
-
批准号:6464633
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2001
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
IFN-ALPHA AND HIV GP120 IN NEUROAIDS STUDIES
-
批准号:6751992
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2000
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
Project 3
-
批准号:6359886
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2000
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
IFN-ALPHA AND HIV GP120 IN NEUROAIDS STUDIES
-
批准号:6846220
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2000
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
IFN-ALPHA AND HIV GP120 IN NEUROAIDS STUDIES
-
批准号:6639215
-
项目类别:
-
资助金额:$34.33万
-
财政年份:2000
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
IFN-ALPHA AND HIV GP120 IN NEUROAIDS STUDIES
-
批准号:6392889
-
项目类别:
-
资助金额:$44.33万
-
财政年份:2000
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
IFN-ALPHA AND HIV GP120 IN NEUROAIDS STUDIES
-
批准号:6146818
-
项目类别:
-
资助金额:$44.18万
-
财政年份:2000
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
THE ROLE OF CYTOKINES IN THE PATHOGENESIS OF AIDS DEMENTIA COMPLEX
-
批准号:6219128
-
项目类别:
-
资助金额:$0.44万
-
财政年份:1999
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
THE ROLE OF CYTOKINES IN THE PATHOGENESIS OF AIDS DEMENTIA COMPLEX
-
批准号:6325996
-
项目类别:
-
资助金额:$33.72万
-
财政年份:1999
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
THE ROLE OF CYTOKINES IN THE PATHOGENESIS OF AIDS DEMENTIA COMPLEX
-
批准号:6273479
-
项目类别:
-
资助金额:$25.69万
-
财政年份:1998
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
THE ROLE OF CYTOKINES IN THE PATHOGENESIS OF AIDS DEMENTIA COMPLEX
-
批准号:6111527
-
项目类别:
-
资助金额:$0.44万
-
财政年份:1998
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
Interleukin 12 in inflammatory neurological diseases
-
批准号:6682717
-
项目类别:
-
资助金额:$5.3万
-
财政年份:1997
-
负责人:IAIN Leslie CAMPBELL
-
依托单位:
INFLAMMATORY NEUROLOGICAL DISEASES
-
批准号:6126354
-
项目类别:
-
资助金额:$20.85万
-
财政年份:1997
-
负责人:IAIN Leslie CAMPBELL
-
依托单位: